Liao Z - Search Results

1

Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.

Moding EJ, Liu Y, Nabet BY, Chabon JJ, Chaudhuri AA, Hui AB, Bonilla RF, Ko RB, Yoo CH, Gojenola L, Jones CD, He J, Qiao Y, Xu T, Heymach JV, Tsao A, Liao Z, Gomez DR, Das M, Padda SK, Ramchandran KJ, Neal JW, Wakelee HA, Loo BW Jr, Lin SH, Alizadeh AA, Diehn M. Moding EJ, et al. Among authors: liao z. Nat Cancer. 2020 Feb;1(2):176-183. doi: 10.1038/s43018-019-0011-0. Epub 2020 Jan 20. Nat Cancer. 2020. PMID: 34505064 Free PMC article.

2

Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer.

Gopal R, Starkschall G, Tucker SL, Cox JD, Liao Z, Hanus M, Kelly JF, Stevens CW, Komaki R. Gopal R, et al. Among authors: liao z. Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):114-20. doi: 10.1016/s0360-3016(03)00077-4. Int J Radiat Oncol Biol Phys. 2003. PMID: 12694829

3

Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection.

Taylor NA, Liao ZX, Cox JD, Stevens C, Roth J, Walsh G, Chang JY, Guerrero T, Jeter M, Putnam J Jr, Fossella FV, Allen P, Komaki R. Taylor NA, et al. Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):204-12. doi: 10.1016/s0360-3016(03)01575-x. Int J Radiat Oncol Biol Phys. 2004. PMID: 14697440

4

Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer.

Komaki R, Liao Z, Milas L. Komaki R, et al. Among authors: liao z. Semin Oncol. 2004 Feb;31(1 Suppl 1):47-53. doi: 10.1053/j.seminoncol.2003.12.014. Semin Oncol. 2004. PMID: 14981580 Review.

5

Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.

Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R. Murshed H, et al. Among authors: liao z. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1258-67. doi: 10.1016/j.ijrobp.2003.09.086. Int J Radiat Oncol Biol Phys. 2004. PMID: 15001271

6

Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.

Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R. Liu HH, et al. Among authors: liao z. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1268-79. doi: 10.1016/j.ijrobp.2003.09.085. Int J Radiat Oncol Biol Phys. 2004. PMID: 15001272

7

Epidermal growth factor receptor as a target to improve treatment of lung cancer.

Andratschke NH, Dittmann KH, Mason KA, Fan Z, Liao Z, Komaki R, Ang KK, Milas L. Andratschke NH, et al. Among authors: liao z. Clin Lung Cancer. 2004 May;5(6):340-52. doi: 10.3816/CLC.2004.n.012. Clin Lung Cancer. 2004. PMID: 15217533 Review.

8

High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy.

Chang JY, Komaki R, Sasaki R, Liao Z, Stevens CW, Lu C, Fossella FV, Allen PK, Cox JD, Spitz MR, Wu X. Chang JY, et al. Among authors: liao z. Clin Cancer Res. 2005 Apr 15;11(8):2894-8. doi: 10.1158/1078-0432.CCR-04-2176. Clin Cancer Res. 2005. PMID: 15837739

9

A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.

Liao Z, Komaki R, Milas L, Yuan C, Kies M, Chang JY, Jeter M, Guerrero T, Blumenschien G, Smith CM, Fossella F, Brown B, Cox JD. Liao Z, et al. Clin Cancer Res. 2005 May 1;11(9):3342-8. doi: 10.1158/1078-0432.CCR-04-1741. Clin Cancer Res. 2005. PMID: 15867233 Clinical Trial.

10

Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy.

Komaki R, Chang JY, Wu X, Allen PK, Milas L, Liao Z, Fossella FV, Travis E, Spitz MR. Komaki R, et al. Among authors: liao z. Semin Oncol. 2005 Apr;32(2 Suppl 3):S92-8. doi: 10.1053/j.seminoncol.2005.03.016. Semin Oncol. 2005. PMID: 16015542 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,342 results

Search Page